Key result
Systolic blood pressure exhibited a U-shaped relationship with all-cause mortality regardless of glucose status, with both SBP <100 mmHg and ≥150 mmHg significantly increasing mortality risk.
Why the study?
Optimal blood pressure levels for diabetic patients remain controversial, and evidence on blood pressure management for individuals with normoglycemia or prediabetes is limited.
Does systolic blood pressure level affect all-cause and cardiovascular mortality in adults with normoglycemia, prediabetes, and diabetes?
Cohort (n=40,046)
Yes
Does systolic blood pressure level affect all-cause and cardiovascular mortality in adults with normoglycemia, prediabetes, and diabetes?
The optimal systolic blood pressure for minimizing mortality follows a U-shaped curve and is progressively higher in individuals with worsening glycemic status (115-120 mmHg for normoglycemia, 120-130 mmHg for prediabetes, and 125-135 mmHg for diabetes).
BACKGROUND: The optimal blood pressure (BP) level for diabetic patients remains controversial, while studies provided limited evidence on BP management for individuals with normoglycemia or prediabetes. We aimed to investigate the associations between systolic blood pressure (SBP) and all-cause and cardiovascular (CVD) mortality among US adults with different glycemic profiles. METHODS: We used data from the 1999-2014 National Health and Nutrition Examination Survey (NHANES, n=40,046) with comprehensive baseline examination and follow-up assessment. Restricted cubic spline analysis was performed to examine dose-response relationship between SBP and mortality risk. Cox regression models were used to estimate hazard ratios of all-cause mortality and CVD mortality for SBP categories. RESULTS: U-shaped associations between SBP and all-cause mortality were observed regardless of glucose status. The relationship between SBP and CVD mortality was found to be U-shaped only in normoglycemic participants. The lowest mortality risk of optimal SBP (mmHg) by group was 115-120 (normoglycemia), 120-130 (prediabetes), and 125-135 (diabetes). When compared with the reference group, SBP < 100 mmHg was significantly associated with 49% (HR=1.49, 95% CI: 1.13-1.96), 57% (1.57, 1.07-2.3), and 59% (1.59, 1.12-2.25) higher all-cause mortality risk in people with normoglycemia, prediabetes, and diabetes, respectively. The multivariable-adjusted HRs of all-cause mortality for SBP ≥150 mmHg were 1.51 (1.25-1.82), 1.56 (1.27-1.93), and 1.33 (1.08-1.64), respectively. As for CVD mortality, the multivariable-adjusted HRs were 2.85 (1.29-6.33) for SBP <100 mmHg and 2.71 (1.56-4.69) for SBP ≥150 mmHg in normoglycemia; HR was 1.66 (1.05-2.63) for SBP ≥150 mmHg in diabetic patients. CONCLUSION: U-shaped relationships between SBP and all-cause mortality were observed regardless of diabetes status. The optimal SBP range was gradually higher with worsening glucose status.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2020) conducted a cohort in Normoglycemia, prediabetes, and diabetes (n=40,046). Systolic blood pressure levels vs. Systolic blood pressure 110-119 mmHg was evaluated on All-cause mortality (SBP < 100 mmHg vs 110-119 mmHg in normoglycemia) (HR 1.49, 95% CI 1.13-1.96, p=<0.05). Systolic blood pressure exhibited a U-shaped relationship with all-cause mortality regardless of glucose status, with both SBP <100 mmHg and ≥150 mmHg significantly increasing mortality risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: